Katsuhito Asai
Direktor/Vorstandsmitglied bei Gene Therapy Research Institution Co., Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Hidetoshi Mine | M | 73 |
Ridgeway Capital Partners Ltd.
Ridgeway Capital Partners Ltd. Investment ManagersFinance Ridgeway Capital Partners Ltd. (RCP) is an independent, partner-owned venture capital firm which specializes in private equity investments. Established in 2001 as Principal Investment Group of Investment Banking Headquarters, Orix Corporation, the firm became OPE Partners Ltd. in 2004 when they were spun-off from Orix Corporation. In 2006, the firm's partners launched an MBO, changing the firm's name to Ridgeway Capital Partners Ltd. in 2007. Headquartered in Tokyo, RCP provides private equity investments and management consulting services. | 20 Jahre |
Shunta Nojiri | M | - |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | - |
Shinichi Muramatsu | M | - |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | - |
Kiyoyuki Katsumata | M | - |
Ridgeway Capital Partners Ltd.
Ridgeway Capital Partners Ltd. Investment ManagersFinance Ridgeway Capital Partners Ltd. (RCP) is an independent, partner-owned venture capital firm which specializes in private equity investments. Established in 2001 as Principal Investment Group of Investment Banking Headquarters, Orix Corporation, the firm became OPE Partners Ltd. in 2004 when they were spun-off from Orix Corporation. In 2006, the firm's partners launched an MBO, changing the firm's name to Ridgeway Capital Partners Ltd. in 2007. Headquartered in Tokyo, RCP provides private equity investments and management consulting services. | 20 Jahre |
Toshiki Kano | M | - |
Ridgeway Capital Partners Ltd.
Ridgeway Capital Partners Ltd. Investment ManagersFinance Ridgeway Capital Partners Ltd. (RCP) is an independent, partner-owned venture capital firm which specializes in private equity investments. Established in 2001 as Principal Investment Group of Investment Banking Headquarters, Orix Corporation, the firm became OPE Partners Ltd. in 2004 when they were spun-off from Orix Corporation. In 2006, the firm's partners launched an MBO, changing the firm's name to Ridgeway Capital Partners Ltd. in 2007. Headquartered in Tokyo, RCP provides private equity investments and management consulting services. | 19 Jahre |
Takashi Nishibori | M | 64 |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | 6 Jahre |
Toshihiko Sato | M | - |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | - |
Masako Kawase | M | - |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | - |
Tsuyoshi Teshima | M | - |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Masayuki Morikage | M | 57 |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | - |
Yasuo Iitomi | M | 77 |
Gene Therapy Research Institution Co., Ltd.
Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Japan | 11 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Katsuhito Asai
- Persönliches Netzwerk